Morganti Legal, a cross-border law firm focused on representing investors, announces that a putative class action has been commenced on behalf of all investors who purchased shares of Nobilis Health Corp. (TSX: “NHC” and FRA: “NH1”) during the period from and including March 23, 2015 to and including October 9, 2015.
A shareholder of Nobils Health Corp. alleges on behalf of all eligible investors, that during the Class Period Nobilis’ accounting for its acquisitions of Athas and First Nobilis, as found in its FYE 2014 and Q1 and Q2 2015 financial statements, were incorrect and resulted in an overstatement of goodwill as well as provided the investing public with a misleading view of the Company’s revenues, expenses, and general business operations.
On January 5, 2016, Nobilis announced that it was restating its previously published consolidated financial statements for the year ended December 31, 2014, first quarter 2015, and second quarter 2015. The Company also announced that its registration statement published during October 2015 should no longer be relied upon by investors. Nobilis has still yet to publish its third quarter 2015 results.
Investors who purchased shares of Nobilis Health Corp. on the Toronto Stock Exchange and Frankfurt Stock Exchange between March 23, 2015 and October 9, 2015 are encouraged to stay informed and protect their rights. You may contact Morganti Legal at (888) 226-0845 or by email at firstname.lastname@example.org for further information.
Morganti Legal is comprised of experienced attorneys that investigate, litigate and resolve economic and financial disputes. You may learn more about Morganti Legal at www.morgantilegal.com. The Firm currently represents investors that purchased securities of Allied Nevada Gold Corp., BP plc., Detour Gold Corporation, Ithaca Energy Limited, North American Palladium, Ltd., MDC Partners, Inc., Silvercorp Metals Inc., Tesco plc., and Valeant Pharmaceuticals International Inc.
This press release may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules.